Analyst Ratings for Syros Pharmaceuticals (SYRS) [Buys]
SYRS Rating Summary
SYRS Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$19.67 (+333.2%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/10/2020 | Brookline Capital Markets » Updated 12/26/2023 |
Leah Rush Cann | New Coverage | Buy (N/A) |
37.00 (48.00) |
8.89 (4.54) |
-48.93% | Details |
| 11/4/2020 | H.C. Wainwright » Updated 5/17/2022 |
Andrew Fein | Upgrade | Buy (Neutral) |
10.00 (15.00) |
7.58 (4.54) |
-40.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
